LINC-ROR stimulates cancer stem cell phenotype and ESCC progression through the deregulation of SOX9, as a TF involved in embryogenesis and maintenance of stem/progenitor cells, to coordinately promote cell proliferation, motility, self-renewal capacity, and cancer stemness state[53]. This evidence concerns the gene SOX9 and esophageal squamous cell carcinoma.